V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16627172 | 330006885 | EUJ01 | 5.6 | null | 1 | 2016-12-15 | NOT CHEMO | 330005625 | 330003652 | 330006887 |
| 16627173 | 330006887 | EZ102 | 1.5 | X729 | 1 | 2016-06-10 | AZD9150 | 330005649 | 330003655 | 330006889 |
| 16627174 | 330006887 | EGU02 | 76 | X721 | 1 | 2016-06-10 | IFOSFAMIDE | 330005649 | 330003655 | 330006889 |
| 16627175 | 330006887 | EEI00 | 4240 | x724 | 1 | 2016-06-10 | ETOPOSIDE | 330005649 | 330003655 | 330006889 |
| 16627176 | 330006887 | EK1EN | 820 | null | 1 | 2016-06-10 | DOCETAXEL | 330005649 | 330003655 | 330006889 |
| 16627177 | 330006887 | ECL01 | null | X724 | 1 | 2016-06-11 | CYTARABINE | 330005649 | 330003655 | 330006889 |
| 16627178 | 330006887 | EEI00 | 20 | null | 1 | 2016-06-12 | VINCRISTINE | 330005649 | 330003655 | 330006889 |
| 16627179 | 330006887 | ERA20 | 150 | X721 | 1 | 2016-06-12 | CISPLATIN | 330005649 | 330003655 | 330006889 |
| 16627180 | 330006887 | EW100 | 128 | X721 | 1 | 2016-06-12 | CISPLATIN | 330005649 | 330003655 | 330006889 |
| 16627181 | 330006887 | ECL02 | 1000 | X721 | 1 | 2016-06-12 | FLUOROURACIL | 330005649 | 330003655 | 330006889 |
| 16627182 | 330006888 | EXO | 3840 | null | 1 | 2018-02-13 | MULTIPLE | 330005651 | 330003656 | 330006890 |
| 16627183 | 330006889 | EUZ | 200 | null | 1 | 2014-03-26 | ETOPOSIDE | 330005651 | 330003656 | 330006891 |
| 16627184 | 330006889 | EEI00 | 4720 | X729 | 2 | 2014-03-26 | VINCRISTINE | 330005651 | 330003656 | 330006891 |
| 16627185 | 330006889 | EKA | 72.5 | null | 1 | 2014-03-26 | CETUXIMAB | 330005651 | 330003656 | 330006891 |
| 16627199 | 330006891 | EEI00 | 3600 | null | 1 | 2016-11-30 | AVELUMAB | 330005676 | 330003658 | 330006893 |
| 16627200 | 330006892 | EGU08 | 55 | null | 1 | 2017-01-12 | IFOSFAMIDE | 330005679 | 330003660 | 330006894 |
| 16627201 | 330006892 | EE813 | 196 | null | 1 | 2017-01-13 | ETOPOSIDE | 330005679 | 330003660 | 330006894 |
| 16627202 | 330006892 | EEI00 | 72.5 | X292 | 2 | 2017-01-13 | TRIAL | 330005679 | 330003660 | 330006894 |
| 16627203 | 330006892 | EEI00 | 1.1 | x724 | 2 | 2017-01-14 | TOPOTECAN | 330005679 | 330003660 | 330006894 |
| 16627204 | 330006892 | EUJ01 | 2250 | X724 | 1 | 2017-01-20 | NOT CHEMO | 330005679 | 330003660 | 330006894 |
| 16627205 | 330006893 | EGU08 | 1150 | X728 | 1 | 2017-08-19 | METHOTREXATE | 330005679 | 330003660 | 330006895 |
| 16627206 | 330006893 | EEI00 | 0.75 | null | null | 2017-08-20 | TOPOTECAN | 330005679 | 330003660 | 330006895 |
| 16627207 | 330006893 | EXO | 160 | null | 1 | 2017-08-20 | CETUXIMAB | 330005679 | 330003660 | 330006895 |
| 16627208 | 330006893 | ED301 | 75 | null | 1 | 2017-08-20 | STEROID | 330005679 | 330003660 | 330006895 |
| 16627209 | 330006893 | EJR | 2400 | X724 | 1 | 2017-08-27 | TRIAL | 330005679 | 330003660 | 330006895 |
| 16627210 | 330006893 | EEI00 | 110 | X724 | 1 | 2017-08-28 | IFOSFAMIDE | 330005679 | 330003660 | 330006895 |
| 16627211 | 330006893 | ETG01 | 1350 | null | 1 | 2017-08-28 | FLUOROURACIL | 330005679 | 330003660 | 330006895 |
| 16627212 | 330006893 | EN201 | 1500 | X721 | 1 | 2017-08-28 | FLUOROURACIL | 330005679 | 330003660 | 330006895 |
| 16627213 | 330006893 | ES4DU | 128 | X721 | 1 | 2017-08-28 | CISPLATIN | 330005679 | 330003660 | 330006895 |
| 16627214 | 330006893 | ERA20 | 8 | X724 | 1 | 2017-08-28 | DEXAMETHASONE | 330005679 | 330003660 | 330006895 |
| 16627215 | 330006893 | EWM01 | 700 | X722 | 1 | 2017-08-29 | RITUXIMAB | 330005679 | 330003660 | 330006895 |
| 16627216 | 330006893 | EUZ | 20 | X724 | 1 | 2017-08-29 | STEROID | 330005679 | 330003660 | 330006895 |
| 16627217 | 330006894 | EEI00 | 2640 | X729 | 1 | 2018-08-07 | CISPLATIN | 330005686 | 330007976 | 330006896 |
| 16627218 | 330006895 | EN710 | 78 | X729 | 1 | 2016-05-04 | ETOPOSIDE | 330005691 | 330003669 | 330006897 |
| 16627219 | 330006895 | EE813 | 7.1 | null | 1 | 2016-05-05 | TRIAL | 330005691 | 330003669 | 330006897 |
| 16627220 | 330006896 | E1UZ0 | 130 | X724 | 1 | null | ETOPOSIDE | 330005694 | 330007977 | 330006898 |
| 16627221 | 330006896 | EK1EN | 20 | X724 | null | null | DACTINOMYCIN | 330005694 | 330007977 | 330006898 |
| 16627222 | 330006896 | E0N03 | 160 | X729 | 1 | null | DOCETAXEL | 330005694 | 330007977 | 330006898 |
| 16627223 | 330006899 | EUZ | 150 | null | 2 | 2013-05-30 | IFOSFAMIDE | 330005701 | 330003674 | 330006901 |
| 16627224 | 330006899 | EK1EN | 450 | null | 1 | 2013-05-30 | NOT CHEMO | 330005701 | 330003674 | 330006901 |
| 16627225 | 330006899 | EGU08 | 3040 | X721 | 1 | 2013-05-30 | VINCRISTINE | 330005701 | 330003674 | 330006901 |
| 16627226 | 330006899 | ELW | 185 | X729 | null | 2013-05-30 | STEROID | 330005701 | 330003674 | 330006901 |
| 16627227 | 330006899 | EE813 | 170 | null | 1 | 2013-05-30 | CYCLOPHOSPHAMIDE | 330005701 | 330003674 | 330006901 |
| 16627228 | 330006899 | EEI00 | 20 | x724 | 1 | 2013-05-30 | NOT CHEMO | 330005701 | 330003674 | 330006901 |
| 16627229 | 330006899 | EE813 | 98 | null | null | 2013-05-30 | CISPLATIN | 330005701 | 330003674 | 330006901 |
| 16627230 | 330006899 | EXO | 1300 | X724 | 1 | 2013-05-30 | FLUOROURACIL | 330005701 | 330003674 | 330006901 |
| 16627231 | 330006899 | EKA | 10 | X724 | 2 | 2013-06-03 | NOT CHEMO | 330005701 | 330003674 | 330006901 |
| 16627232 | 330006899 | EGENG | 136 | X724 | 1 | 2013-06-03 | CISPLATIN | 330005701 | 330003674 | 330006901 |
| 16627233 | 330006899 | EYATY | 130 | X724 | 1 | 2013-06-04 | BENDAMUSTINE | 330005701 | 330003674 | 330006901 |
| 16627234 | 330006899 | EJN | 400 | X721 | 1 | 2013-06-04 | CARBOPLATIN | 330005701 | 330003674 | 330006901 |